Communiqués Allergan plc

Actions

AGN

IE00BY9D5467

Produits pharmaceutiques

Temps Différé Nyse Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		+1,73 %	+0,97 %

12/02	Allergan Aesthetics lance trois nouveaux centres de formation aux États-Unis pour élargir l'accès à une formation esthétique de haute qualité	CI
2024	BOTOX® Cosmétique (onabotulinumtoxinA) reçoit l'approbation de la FDA pour les bandes verticales modérées à sévères reliant la mâchoire et le cou (bandes platysma)	CI

Communiqués

Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement	01/04/24	AQ
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	20/04/22	AQ
Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY 1.25% in Adults with Age-Related Blurry Near Vision	06/04/22	AQ
AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting	22/03/22	AQ
Allergan - VUITY 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry near Vision, is Now Available	10/12/21	AQ
Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the Treatment of Presbyopia	27/10/21	AQ
Hagens Berman: Law Firm Investigating Permanent Injuries and Disfigurement from Botched CoolSculpting Procedures	05/10/21	BU
AbbVie : Allergan - FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity	30/07/21	AQ
AbbVie : Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting	21/07/21	AQ
Stamp Duty Battle: Abbvie Wins Appeal Against €587m Irish Stamp Duty	16/04/21	AQ
AbbVie : Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference	18/01/21	AQ
Allergan : an AbbVie company to Share New Data at American Academy of Ophthalmology 2020 Virtual	09/11/20	AQ
AbbVie : Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia	29/10/20	AQ
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Allergan plc and Encourages Investors with Losses of $100,000 to Contact the Firm	29/10/20	BU
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allergan plc and Encourages Investors with Losses of $100,000 to Contact the Firm	26/10/20	BU
Allergan : ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Allergan plc Investors to Contact Firm Before Important October 29 Deadline in Class Action Seeking Recovery of Investor Losses; Encourages Investors with Losses in Excess of $500K to Contact the Firm - AGN	15/10/20	PR
Allergan : AGN Shareholder Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Allergan plc and New Lead Plaintiff Deadline – October 29, 2020	15/10/20	BU
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Allergan plc Investors to Contact Firm Before Important October 29 Deadline in Class Action Seeking Recovery of Investor Losses – AGN	09/10/20	BU
Allergan : an AbbVie Company, and Von Miller Encourage People with Glaucoma to Design Their Disease Management Plan	09/10/20	AQ
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allergan plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm	05/10/20	BU
Allergan : AGN Investor Alert - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Allergan plc and Lead Plaintiff Deadline - October 29, 2020	01/10/20	PR
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allergan plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm	01/10/20	BU
AbbVie : Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol	29/06/20	AQ
TherapeuticsMD : Announces Appointment of James C. D'Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer	02/06/20	AQ
AbbVie : Completes Transformative Acquisition of Allergan	11/05/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Allergan plc

Actions

AGN

IE00BY9D5467

Produits pharmaceutiques

Communiqués

Filtres